The Long-Acting Vasoactive Intestinal Polypeptide Agonist RO 25-1553 Is Highly Selective of the VIP 2 Receptor Subclass

Jan 1, 1997Peptides

The long-lasting VIP-like drug RO 25-1553 targets the VIP2 receptor subtype

AI simplified

Abstract

RO 25-1553 is threefold more potent than VIP on the human VIP2 receptor.

  • RO 25-1553 induced relaxation of tracheal and bronchial smooth muscles.
  • It reduced edema and eosinophilic mobilization during pulmonary anaphylaxis.
  • The compound acted as a full agonist on the VIP2, PACAP I, and rat VIP1 receptors.
  • It was a partial agonist on the human VIP1 receptor.
  • RO 25-1553 displayed varying potency across different receptor subclasses.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free